Close
Courage over Cancer Filtered Blog
Breaking New Ground in Pediatric Bone Cancer Research: How discoveries in San Antonio are opening new therapeutic opportunities for children with osteosarcoma
By Panneerdoss Subbarayalu, PhD This article was first published in the September 2026 issue of the Bexar County Medical Society’s San Antonio Medicine magazine. Osteosarcoma is an aggressive cancer that grows quickly, spreads early to the lungs, and has a remarkable ability to resist treatment. It is the most common primary bone cancer in children […]
Read more
UT Health San Antonio names NIH expert inaugural director of stem cell transplant and cellular therapy program
UT Health San Antonio, the academic health center and health system of The University of Texas at San Antonio (UT San Antonio), has named nationally recognized blood cancer and cellular therapy expert Georg Aue, MD, PhD, MBA, the director of the Stem Cell Transplant and Cellular Therapy Program at the Mays Cancer Center, the only National […]
Read more
Clearing the air on the lung cancer risks we often ignore
One of the biggest misconceptions about lung cancer is that it only affects people who smoke.
Read more
The ultimate tune-up: Why staying ahead of your health is the smartest move for your family
When we ask men in our community what matters most to them, they rarely mention medical charts or numbers. Instead, they talk about family.
Read more
Researchers uncover potential strategy for safer cancer treatments
Scientists at The University of Texas at San Antonio discovered a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
Read moreGLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual […]
Read more